Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Entuzity Kwikpens
| Field | Information |
|---|---|
| Medication Name | Entuzity Kwikpens |
| Generic Name | Erenumab-aooe |
| Purpose | Preventive treatment of migraine in adults |
| Mechanism of Action | Calcitonin Gene-Related Peptide (CGRP) receptor antagonist |
| Dosage Forms | Subcutaneous injection (prefilled pen) |
| Available Strengths | 70 mg/mL, 140 mg/mL |
| Dosage Frequency | Once monthly |
| Common Side Effects | Injection site reactions (pain, redness), constipation, muscle cramps |
| Serious Side Effects | Hypersensitivity reactions (rash, itching, swelling), constipation with serious complications |
| Drug Interactions | No significant drug interactions reported. Consult with a healthcare provider about all medications and supplements. |
| Important Notes | Administer subcutaneously as directed. Store refrigerated. Monitor for hypersensitivity reactions. |
| Storage | Store refrigerated between 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze. |
| Missed Dose | Administer the missed dose as soon as possible, then resume monthly dosing schedule. |
| Alternatives | Aimovig (erenumab), Ajovy (fremanezumab), Emgality (galcanezumab), Qulipta (atogepant) |
Entuzity Kwikpens Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Aimovig (erenumab) | CGRP receptor antagonist | Similar mechanism to Entuzity; monthly subcutaneous injection. |
| Ajovy (fremanezumab) | CGRP ligand antagonist | Monthly or quarterly subcutaneous injection. |
| Emgality (galcanezumab) | CGRP ligand antagonist | Monthly subcutaneous injection. |
| Qulipta (atogepant) | CGRP receptor antagonist | Oral medication taken daily. |
Entuzity Kwikpens Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Injection site reactions (pain, redness) | Hypersensitivity reactions (rash, itching, swelling) |
| Constipation | Constipation with serious complications (e.g., bowel obstruction) |
| Muscle cramps | High blood pressure |
Entuzity Kwikpens Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Migraine Prevention | 70 mg or 140 mg | 70 mg or 140 mg once monthly | Administer subcutaneously. Rotate injection sites. |
Entuzity Kwikpens Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50,000 |
| Without Insurance (U.S.) | $419,500 – $450,000 |
| From CPS | $161.30 |

